Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors

被引:11
|
作者
Oyama, Rieko [1 ]
Kito, Fusako [1 ]
Takahashi, Mami [2 ]
Hattori, Emi [3 ]
Noguchi, Rei [3 ]
Takai, Yoko [1 ]
Sakumoto, Marimu [1 ]
Qiao, Zhiwei [3 ]
Toki, Shunichi [4 ]
Sugawara, Masato [4 ]
Tanzawa, Yoshikazu [4 ]
Kobayashi, Eisuke [4 ]
Nakatani, Fumihiko [4 ]
Iwata, Shintaro [4 ]
Yoshida, Akihiko [5 ,6 ]
Kawai, Akira [4 ]
Kondo, Tadashi [1 ,3 ]
机构
[1] Natl Canc Ctr, Res Inst, Dept Innovat Seeds Evaluat, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Cent Anim Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[3] Natl Canc Ctr, Res Inst, Div Rare Canc Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[4] Natl Canc Ctr, Div Musculoskeletal Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[5] Natl Canc Ctr, Dept Pathol, Chuo Ku, Tokyo 1040045, Japan
[6] Natl Canc Ctr, Clin Labs, Chuo Ku, Tokyo 1040045, Japan
关键词
Malignant peripheral nerve sheath tumor; Xenograft; Primary culture; Drug screening; PHASE-II; SOMATIC MUTATIONS; READ ALIGNMENT; TRANSFORMATION; SUZ12; PRC2;
D O I
10.1186/s12935-020-1128-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Malignant peripheral nerve sheath tumors (MPNSTs) are a rare subtype of soft-tissue sarcoma, derived from a peripheral branch or the sheath of the sciatic nerve, brachial plexus, or sacral plexus. The clinical outcomes for MPNST patients with unresectable or metastatic tumors are dismal, and novel therapeutic strategies are required. Although patient-derived cancer cell lines are vital for basic research and preclinical studies, few MPNST cell lines are available from public cell banks. Therefore, the aim of this study was to establish cancer cell lines derived from MPNST patients. Methods We used tumor tissues from five patients with MPNSTs, including one derived from a rare bone tissue MPNST. The tumor tissues were obtained at the time of surgery and were immediately processed to establish cell lines. A patient-derived xenograft was also established when a sufficient amount of tumor tissue was available. The characterization of established cells was performed with respect to cell proliferation, spheroid formation, and invasion. The mutation status of actionable genes was monitored by NCC Oncopanel, by which the mutation of 114 genes was assessed by next-generation sequencing. The response to anti-cancer agents, including anti-cancer drugs approved for the treatment of other malignancies was investigated in the established cell lines. Results We established five cell lines (NCC-MPNST1-C1, NCC-MPNST2-C1, NCC-MPNST3-C1, NCC-MPNST4-C1, and NCC-MPNST5-C1) from the original tumors, and also established patient-derived xenografts (PDXs) from which one cell line (NCC-MPNST3-X2-C1) was produced. The established MPNST cell lines proliferated continuously and formed spheroids while exhibiting distinct invasion abilities. The cell lines had typical mutations in the actionable genes, and the mutation profiles differed among the cell lines. The responsiveness to examined anti-cancer agents differed among cell lines; while the presence of an actionable gene mutation did not correspond with the response to the anticipated anti-cancer agents. Conclusion The established cell lines exhibit various characteristics, including proliferation and invasion potential. In addition, they had different mutation profiles and response to the anti-cancer agents. These observations suggest that the established cell lines will be useful for future research on MPNSTs.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Imaging of malignant peripheral nerve sheath tumors
    Murphey, MD
    Smith, WS
    Temple, HT
    RADIOLOGY, 1996, 201 : 1258 - 1258
  • [22] Facial malignant peripheral nerve sheath tumors
    Martin-Duverneuil, N.
    Auriol, M.
    Behin, A.
    Bertrand, J. C.
    Chiras, J.
    JOURNAL OF NEURORADIOLOGY, 2006, 33 (04) : 237 - 249
  • [23] Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities
    Creus-Bachiller, Edgar
    Fernandez-Rodriguez, Juana
    Magallon-Lorenz, Miriam
    Ortega-Bertran, Sara
    Navas-Rutete, Susana
    Romagosa, Cleofe
    Silva, Tulio M.
    Pane, Maria
    Estival, Anna
    Sidelnikova, Diana Perez
    Morell, Mireia
    Mazuelas, Helena
    Carrio, Meritxell
    Lausova, Tereza
    Reuss, David
    Gel, Bernat
    Villanueva, Alberto
    Serra, Eduard
    Lazaro, Conxi
    MOLECULAR ONCOLOGY, 2024, 18 (04) : 895 - 917
  • [24] Cutaneous malignant peripheral nerve sheath tumors
    Thomas, Crystal
    Somani, Najwa
    Owen, Lafayette G.
    Malone, Janine C.
    Billings, Steven D.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2009, 36 (08) : 896 - 900
  • [25] Malignant peripheral nerve sheath tumors: Analysis of the national cancer database
    Mowery, Alia
    Clayburgh, Daniel
    ORAL ONCOLOGY, 2019, 98 : 13 - 19
  • [26] Establishment and characterization of patient-derived xenograft models of acute leukemias
    Siegert, A.
    Brzezicha, B.
    Wulf-Goldenberg, A.
    Karawajew, L.
    Fichtner, I.
    Hoffmann, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 116 - 116
  • [27] Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors
    Spyra, Melanie
    Kluwe, Lan
    Hagel, Christian
    Nguyen, Rosa
    Panse, Jens
    Kurtz, Andreas
    Mautner, Victor Felix
    Rabkin, Samuel David
    Demestre, Maria
    PLOS ONE, 2011, 6 (06):
  • [28] Malignant peripheral nerve sheath tumors of intrathoracic vagus nerve
    Ogino, H
    Hara, M
    Satake, M
    Miyagawa, H
    Itoh, M
    Ohba, S
    Goodman, PC
    JOURNAL OF THORACIC IMAGING, 2001, 16 (03) : 181 - 184
  • [29] Establishment and characterization of a recurrent malignant peripheral nerve sheath tumor cell line: RsNF
    Zhang, Xingnan
    Hu, Chenhao
    Li, Dezhi
    Liu, Song
    HUMAN CELL, 2024, 37 (01) : 345 - 355
  • [30] Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line
    Longo, Jody Fromm
    Brosius, Stephanie N.
    Znoyko, Iya
    Alers, Victoria A.
    Jenkins, Dorea P.
    Wilson, Robert C.
    Carroll, Andrew J.
    Wolff, Daynna J.
    Roth, Kevin A.
    Carro, Steven L.
    SCIENTIFIC REPORTS, 2021, 11 (01)